Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid [SUPPLEMENT]
Published: 24 June 2022| Version 1 | DOI: 10.17632/pp8zw5hvh8.1
Contributors:
Jordan Said,
Jordan Talia,
Erin Wei,
Arash Mostaghimi,
Yevgeniy Semenov,
Anita Giobbie-Hurder,
Steven Chen,
Nicole LeBoeuf
Description
This Mendeley Supplement accompanies the research letter "Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid," an article published in the Journal of the American Academy of Dermatology.
Files
Categories
Dermatology, Oncology, Bullous Disease, Immune Checkpoint Inhibitor